South Korea Parenteral Nutrition Market Size & Outlook
South Korea parenteral nutrition market, 2018-2030 (US$M)
Related Markets
South Korea parenteral nutrition market highlights
- The South Korea parenteral nutrition market generated a revenue of USD 129.5 million in 2023 and is expected to reach USD 218.5 million by 2030.
- The South Korea market is expected to grow at a CAGR of 7.8% from 2024 to 2030.
- In terms of segment, oral was the largest revenue generating product in 2023.
- Oral is the most lucrative product segment registering the fastest growth during the forecast period.
Parenteral nutrition market data book summary
| Market revenue in 2023 | USD 129.5 million |
| Market revenue in 2030 | USD 218.5 million |
| Growth rate | 7.8% (CAGR from 2023 to 2030) |
| Largest segment | Oral |
| Fastest growing segment | Oral |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral, Enteral |
| Key market players worldwide | Baxter International Inc, Allergan, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical, Grifols SA Ordinary Shares - Class A, B. Braun, CSL Ltd, Fresenius SE & Co KGaA, Pfizer Inc, Sichuan Kelun Pharmaceutical |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.8% of the global parenteral nutrition market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China parenteral nutrition market is projected to lead the regional market in terms of revenue in 2030.
- South Korea is the fastest growing regional market in Asia Pacific and is projected to reach USD 218.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Parenteral Nutrition Market Scope
Parenteral Nutrition Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea parenteral nutrition market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to parenteral nutrition market will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 86.56% in 2023. Horizon Databook has segmented the South Korea parenteral nutrition market based on oral, enteral covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea has a large elderly population; thus, the need for clinical nutrition and enteral feeding is high. For instance, according to World Bank data, in 2022, the percentage of people aged 65 and above was 17% of the total population.
Moreover, the increase in the incidence of head and neck cancer is another major factor driving the growth of the parenteral nutrition market in South Korea. In 2020, cancer was responsible for 51,269,813 deaths, and 230,317 new cases of cancer were diagnosed in South Korea.
Reasons to subscribe to South Korea parenteral nutrition market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea parenteral nutrition market databook
-
Our clientele includes a mix of parenteral nutrition market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea parenteral nutrition market , including forecasts for subscribers. This country databook contains high-level insights into South Korea parenteral nutrition market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea parenteral nutrition market size, by stage, 2018-2030 (US$M)
South Korea Parenteral Nutrition Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
